Strs Ohio Makes New $481,000 Investment in OraSure Technologies, Inc. $OSUR

Key Points

• Strs Ohio has invested approximately $481,000 in OraSure Technologies, Inc., acquiring 142,800 shares and holding about 0.19% of the company.
• Other institutional investors have also increased their stakes in OraSure Technologies, contributing to a total institutional ownership of 93.50% of the company's stock.
• As of the recent trading session, OraSure Technologies' stock is valued at $3.38, with a 12-month low of $2.36 and a high of $4.60.

Strs Ohio purchased a new stake in OraSure Technologies, Inc. (NASDAQ:OSUR - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 142,800 shares of the medical instruments supplier's stock, valued at approximately $481,000. Strs Ohio owned about 0.19% of OraSure Technologies at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Spire Wealth Management acquired a new stake in shares of OraSure Technologies in the first quarter valued at approximately $54,000. Assenagon Asset Management S.A. boosted its position in OraSure Technologies by 9.4% during the first quarter. Assenagon Asset Management S.A. now owns 164,260 shares of the medical instruments supplier's stock worth $554,000 after acquiring an additional 14,132 shares during the last quarter. Northern Trust Corp boosted its position in OraSure Technologies by 6.7% during the fourth quarter. Northern Trust Corp now owns 693,887 shares of the medical instruments supplier's stock worth $2,505,000 after acquiring an additional 43,628 shares during the last quarter. Two Sigma Investments LP acquired a new stake in OraSure Technologies during the fourth quarter worth approximately $552,000. Finally, Public Employees Retirement System of Ohio acquired a new stake in OraSure Technologies during the fourth quarter worth approximately $277,000. 93.50% of the stock is currently owned by institutional investors and hedge funds.

OraSure Technologies Stock Performance

NASDAQ OSUR traded down $0.06 during mid-day trading on Monday, reaching $3.32. 499,479 shares of the stock were exchanged, compared to its average volume of 621,724. OraSure Technologies, Inc. has a 1-year low of $2.36 and a 1-year high of $4.60. The business's fifty day simple moving average is $3.15 and its 200 day simple moving average is $3.05. The stock has a market capitalization of $242.82 million, a PE ratio of -4.96 and a beta of 0.44.

OraSure Technologies Company Profile

OraSure Technologies, Inc, together with its subsidiaries, provides point-of-care and home diagnostic tests, specimen collection devices, and microbiome laboratory and analytical services in the United States, Europe, and internationally. The company's products include InteliSwab COVID-19 rapid test, InteliSwab COVID-19 rapid test pro, InteliSwab COVID-19 rapid test rx, OraQuick Rapid HIV test, OraQuick In-Home HIV test, OraQuick HIV self-test, OraQuick HCV rapid antibody test, OraQuick Ebola rapid antigen test, OraSure oral fluid collection device used in conjunction with screening and confirmatory tests for HIV-1 antibodies; Intercept drug testing systems; immunoassay tests and reagents; and Q.E.D.